Data reveal that the expression of ERβ was significantly higher in metastatic lymph node than in the primary NSCLC tumor tissue, which further suggests that ERβ activation may enhance metastatic aggressiveness of lung cancer cells. This evidence concerns the gene ESR2 and non-small cell lung carcinoma.